# TSC BioVenture Management

TSC BioVenture Management is a Venture Capital based in Taipei, Taiwan.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Taipei, Taiwan
- **Region:** Asia
- **Address:** Taipei, Taiwan
- **Founded:** 2002
- **Assets under management:** Undisclosed
- **Website:** http://www.tscbioventures.com
- **LinkedIn:** linkedin.com/company/tsc-bioventure-capital-corporation

## Regulatory record

- **Reports private funds:** No

## About

TSC BioVenture Management is a private equity firm based in Taipei, Taiwan. It focuses on a Venture Capital investment approach.

## Sectors

- Biotech
- Digital Health
- Pharmaceuticals

## People

- Jessie J. Hsu — Managing Director

## Questions

### Who runs investment decisions at TSC BioVenture Management?

Jessie J. Hsu serves as Managing Director and leads investment decisions for TSC BioVenture Management. She oversees the firm's pipeline in early-stage biotech and pharmaceutical investments, drawing on a network that spans Taiwan, the US, and mainland China. Her background includes direct operational and financial experience in the life-sciences sector.

### What investment stages does TSC BioVenture Management typically target?

The firm focuses on early-stage through late-stage venture, including seed, start-up, and expansion rounds, per its structured investment approach. It often participates in Series A and B rounds for biotech platforms and therapeutic assets, occasionally supporting companies through clinical inflection points. The stage agnosticism within venture allows flexibility for capital-intensive drug development timelines.

### Does TSC BioVenture Management participate in fund commitments or only direct deals?

TSC BioVenture Management engages primarily in direct venture investment into private life-science companies, rather than operating as a fund-of-funds. The firm has historically co-invested alongside other specialist healthcare venture funds in syndicated rounds. It does not publicly market separate commingled funds to external allocators as a GP, operating with a mandate tied directly to its own capital base.

### How is TSC BioVenture Management related to Taiwan's broader investment landscape?

The firm represents one of the few Taiwan-headquartered venture platforms specifically dedicated to life sciences, a departure from the island's dominant electronics and semiconductor venture ecosystem. TSC BioVenture channels Taiwanese institutional and private wealth into biotechnology opportunities abroad, particularly in US-based drug development companies. Its existence reflects a structural diversification of cross-border capital flows from Taiwan's technology-generated wealth into healthcare innovation.

## Related profiles

- [Trust Venture Capital](https://altss.com/profile/trust-venture-capital)
- [TSG Equity Partners](https://altss.com/profile/tsg-equity-partners)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/tsc-bioventure-management

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology